HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 2 September 2013

New project: NICE TA of vedolizumab

ScHARR-TAG has been allocated the following topic as part of the NICE Technology Appraisal Programme:

Vedolizumab for ulcerative colitis (Single Technology Appraisal)

The draft scope is available here.